Merck KGaA's novel vitronectin antagonist EMD-121974 enters clinical testing in various cancers Aug. 24, 1999 No Comments
Agouron commences phase III trial of prinomastat for treatment of lung cancer Aug. 20, 1999 No Comments
RSS